Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

FDA clears TAVR guidewire built with BASILICA in mind
The Telltale system was designed to assist cardiologists when BASILICA is required prior to TAVR.
Canon introduces new combined CT-angiography interventional system
Jaimin Chung, director of Canon Medical’s interventional X-ray and vascular business unit, explains the technology behind a new combined CT angiography interventional system aimed at neurology, trauma, stroke and pediatrics that recently received 510(k) FDA clearance.
AI dramatically improves the detection of severe heart attacks
Researchers put an advanced AI model to the test, using it to evaluate the ECG results of more than 1,000 patients. It performed quite well.
FDA clears new-look robotic system from Stereotaxis
GenesisX represents the company’s most accessible robotic system to date. It requires no room shielding or structural anchoring, for example, and the size has been significantly reduced.
Interventional cardiology showing more interest in endovascular procedures
Sahil Parikh, MD, said it was clear at TCT 2025 that the specialty is getting more and more involved with endovascular procedures for stroke, pulmonary embolism and peripheral artery disease.

Adona Medical adjustable interatrial shunt

Heart failure startup raises $33.5M for adjustable interatrial shunt

Adona Medical’s adjustable interatrial shunt can be made larger or smaller in size after implantation through the use of a custom-designed induction catheter.

Jim Melton, DO, vascular surgeon and co-founder of the CardioVascular Health Clinic in Oklahoma City, explains the use of mobile outreach cardiology clinics to help rural and Native American populations.

Mobile cardiology clinic reaches rural, Native American populations in Oklahoma

Jim Melton, DO, a vascular surgeon in Oklahoma City, explains his efforts to reach patients in rural Oklahoma and Native American tribes with a mobile cardiovascular clinic program.

Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock

Impella use may not improve high-risk PCI outcomes

Impella heart pumps may not provide as much value when treating high-risk patients as early data suggested.

Biolimus A9 Coated Balloon from BioAscend

In-stent restenosis after PCI: New biolimus-coated balloon non-inferior to paclitaxel devices

A new study of nearly 300 PCI patients suggests biolimus-coated balloons could provide significant value to interventional cardiologists in the years ahead.

Video interview with Peter Monteleone, MD, explaining the primary catheter-based interventional tools used to treat pulmonary embolism (PE).

A cardiologist's guide to treating pulmonary embolism

Interventional cardiologist Peter Monteleone, MD, discussed the primary tools used to treat pulmonary embolism in the cath lab.

Video of Peter Monteleone, MD, discusses role of cardiology in pulmonary embolism response teams (PERT). CT image of the heart showing bilateral pulmonary embolism blood clots in the pulmonary arteries leading into the lungs.

Interventional cardiology sees growing role in pulmonary embolism interventions

Peter Monteleone, MD, national director of cardiovascular research at Ascension Health, explains the growing role of interventional cardiology in pulmonary embolism treatment and PERT teams.

It’s official: Johnson & Johnson completes $13B Shockwave Medical acquisition

The deal, first announced in April, has been finalized. Shockwave will now operate as a business unit within Johnson & Johnson MedTech, and its common stock is no longer trading on NASDAQ.

Women remain underrepresented in revascularization trials—can cardiology leaders reverse that trend?

“If together we do not just hope for, but demand, adequate representation as a necessary criterion for high-quality studies worthy of adoption into practice, we will have a real shot at achieving true equity in our trials," cardiologists said in a new commentary.

Cath Lab

FDA clears TAVR guidewire built with BASILICA in mind

Canon introduces new combined CT-angiography interventional system

AI dramatically improves the detection of severe heart attacks

FDA clears new-look robotic system from Stereotaxis

Interventional cardiology showing more interest in endovascular procedures